Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-071707·Atea Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Atea Pharmaceuticals Inc
Common Stock, par value $0.001 · CUSIP: 04683R106
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JPM Partners LLC
Shares: 5,866,025 · Class: 6.9%
- Jean-Pierre Sommadossi
Shares: 8,876,453 · Class: 10.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-071707
- Form type
- SCHEDULE 13G/A
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership